Effects of opium consumption on cardiometabolic diseases
- 22 October 2013
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cardiology
- Vol. 10 (12) , 733-740
Abstract
Opium is the second-most-commonly abused substance (after tobacco) in developing countries of the Middle East region, and in many Asian nations. One of the reasons for the high prevalence of opium abuse in these countries is a traditional belief among Eastern people, even including some medical staff, that opium might have beneficial effects on cardiovascular health and in the control of diabetes mellitus, hypertension, and dyslipidaemia. In this Perspectives article, we summarize the current understanding of the pharmacotoxicology of opium and its specific effects on glycaemic control, blood pressure, lipid profile, and atherosclerosis. On the basis of the available evidence, we believe not only that opium has no ameliorating effect on cardiovascular diseases, but also that the use of this drug might have adverse effects on these conditions. Therefore, people should be educated about the hazardous effects of opium consumption on cardiometabolic diseases.Keywords
This publication has 67 references indexed in Scilit:
- Opium Addiction Increases Interleukin 1 Receptor Antagonist (IL-1Ra) in the Coronary Artery Disease PatientsPLOS ONE, 2012
- Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up studyCardiovascular Diabetology, 2012
- μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: From a symposium on new concepts in mu-opioid pharmacologyDrug and Alcohol Dependence, 2012
- The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomesInternational Journal of Epidemiology, 2011
- Opium Consumption and Coronary Atherosclerosis in Diabetic Patients: A Propensity Score-Matched StudyPlanta Medica, 2011
- Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?Lipids in Health and Disease, 2008
- The connection between C‐reactive protein and atherosclerosisAnnals of Medicine, 2008
- Lipids and drugs of abuseLife Sciences, 2005
- Opium revisited: a brief review of its nature, composition, non‐medical use and relative risks1Addiction, 1997
- Morphine-induced alterations in plasma and tissue cholesterol levelsLife Sciences, 1987